Patel, Manesh R.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 9,430

Global Vascular Guidelines on the management of chronic limb-threatening ischemia.

Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery

Peripheral Artery Disease ManagementVascular Procedures and Complications

Cited by 2,015

Global vascular guidelines on the management of chronic limb-threatening ischemia

Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery

Peripheral Artery Disease ManagementVascular Procedures and Complications

Cited by 1,582

Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease

Douglas, P. S., Hoffmann, U., Patel, M. R., Mark, D. B., Al-Khalidi, H. R., Cavanaugh, B., Cole, J., Dolor, R. J., Fordyce, C. B., Huang, M., et al. (2015) · New England Journal of Medicine

Cardiac Imaging and DiagnosticsCoronary Interventions and Diagnostics

Cited by 1,543

Rivaroxaban in Peripheral Artery Disease after Revascularization

Bonaca, M. P., Bauersachs, R. M., Anand, S. S., Debus, E. S., Nehler, M. R., Patel, M. R., Fanelli, F., Capell, W. H., Diao, L., Jaeger, N., et al. (2020) · New England Journal of Medicine

Peripheral Artery Disease ManagementAntiplatelet Therapy and Cardiovascular Diseases

Cited by 1,045

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

Kandzari, D. E., Böhm, M., Mahfoud, F., Townsend, R. R., Weber, M. A., Pocock, S., Tsioufis, K., Tousoulis, D., Choi, J. W., East, C., et al. (2018) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 793

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Townsend, R. R., Mahfoud, F., Kandzari, D. E., Kario, K., Pocock, S., Weber, M. A., Ewen, S., Tsioufis, K., Tousoulis, D., Sharp, A. S. P., et al. (2017) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 752

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Hiatt, W. R., Fowkes, F. G. R., Heizer, G., Berger, J. S., Baumgartner, I., Held, P., Katona, B. G., Mahaffey, K. W., Norgren, L., Jones, W. S., et al. (2017) · New England Journal of Medicine

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 636

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

Fox, K. A. A., Piccini, J. P., Wojdyla, D., Becker, R. C., Halperin, J. L., Nessel, C. C., Paolini, J. F., Hankey, G. J., Mahaffey, K. W., Patel, M. R., et al. (2011) · European Heart Journal

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 608

Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

Böhm, M., Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K., Pocock, S., Konstantinidis, D., Choi, J. W., et al. (2020) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 606

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes

Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2017) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 493

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

Hankey, G. J., Patel, M. R., Stevens, S. R., Becker, R. C., Breithardt, G., Carolei, A., Diener, H.-C., Donnan, G. A., Halperin, J. L., Mahaffey, K. W., et al. (2012) · The Lancet Neurology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 354

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

Breithardt, G., Baumgartner, H., Berkowitz, S. D., Hellkamp, A. S., Piccini, J. P., Stevens, S. R., Lokhnygina, Y., Patel, M. R., Halperin, J. L., Singer, D. E., et al. (2014) · European Heart Journal

Atrial Fibrillation Management and OutcomesCardiac Valve Diseases and Treatments

Cited by 196

PROspective Multicenter Imaging Study for Evaluation of chest pain: Rationale and design of the PROMISE trial

Douglas, P. S., Hoffmann, U., Lee, K. L., Mark, D. B., Al-Khalidi, H. R., Anstrom, K., Dolor, R. J., Kosinski, A., Krucoff, M. W., Mudrick, D. W., et al. (2014) · American Heart Journal

Cardiac Imaging and DiagnosticsCoronary Interventions and Diagnostics

Cited by 141

Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study

Subherwal, S., Patel, M. R., Kober, L., Peterson, E. D., Bhatt, D. L., Gislason, G. H., Olsen, A.-M. S., Jones, W. S., Torp-Pedersen, C., & Fosbol, E. L. (2015) · European Journal of Preventive Cardiology

Peripheral Artery Disease ManagementHealthcare Systems and Public Health

Cited by 129

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

Kandzari, D. E., Townsend, R. R., Kario, K., Mahfoud, F., Weber, M. A., Schmieder, R. E., Pocock, S., Tsioufis, K., Konstantinidis, D., Choi, J., et al. (2023) · Journal of the American College of Cardiology

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 124

Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial

Böhm, M., Mahfoud, F., Townsend, R. R., Kandzari, D. E., Pocock, S., Ukena, C., Weber, M. A., Hoshide, S., Patel, M., Tyson, C. C., et al. (2019) · European Heart Journal

Blood Pressure and Hypertension StudiesHeart Rate Variability and Autonomic Control

Cited by 87

Supervised vs unsupervised exercise for intermittent claudication: A systematic review and meta-analysis

Vemulapalli, S., Dolor, R. J., Hasselblad, V., Schmit, K., Banks, A., Heidenfelder, B., Patel, M. R., & Jones, W. S. (2015) · American Heart Journal

Peripheral Artery Disease ManagementCardiovascular and exercise physiology

Cited by 77

Development and preliminary testing of health equity across the AI lifecycle (HEAAL): a framework for healthcare delivery organizations to mitigate the risk of AI solutions worsening health inequities

Kim, J. Y., Hasan, A., Kellogg, K. C., Ratliff, W., Murray, S. G., Suresh, H., Valladares, A., Shaw, K., Tobey, D., Vidal, D. E., et al. (2024) · PLOS Digital Health

Artificial Intelligence in Healthcare and EducationEthics and Social Impacts of AI

Cited by 61

Organizational Governance of Emerging Technologies: AI Adoption in Healthcare

Kim, J. Y., Boag, W., Gulamali, F., Hasan, A., Hogg, H. D. J., Lifson, M., Mulligan, D., Patel, M., Raji, I. D., Sehgal, A., et al. (2023) · 2023 ACM Conference on Fairness Accountability and Transparency

Artificial Intelligence in Healthcare and EducationEthics and Social Impacts of AI

Cited by 55

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Jolicœur, E. M., O'Neill, W. W., Hellkamp, A., Hamm, C. W., Holmes, D. R., Al-Khalidi, H. R., Patel, M. R., Van de Werf, F. J., Pieper, K., Armstrong, P. W., et al. (2009) · European Heart Journal

Blood transfusion and managementAcute Myocardial Infarction Research

Cited by 54

Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial

Berger, J. S., Katona, B. G., Jones, W. S., Patel, M. R., Norgren, L., Baumgartner, I., Blomster, J., Mahaffey, K. W., Held, P., Millegård, M., et al. (2016) · American Heart Journal

Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management

Cited by 47

Frameworks for procurement, integration, monitoring, and evaluation of artificial intelligence tools in clinical settings: A systematic review

Khan, S. D., Hoodbhoy, Z., Raja, M. H. R., Kim, J. Y., Hogg, H. D. J., Manji, A. A. A., Gulamali, F., Hasan, A., Shaikh, A., Tajuddin, S., et al. (2024) · PLOS Digital Health

Artificial Intelligence in Healthcare and EducationElectronic Health Records Systems

Cited by 36

Evaluating sepsis watch generalizability through multisite external validation of a sepsis machine learning model.

Valan, B., Prakash, A., Ratliff, W., Gao, M., Muthya, S., Thomas, A., Eaton, J. L., Gardner, M., Nichols, M., Revoir, M., et al. (2025) · npj Digital Medicine

Sepsis Diagnosis and TreatmentMachine Learning in Healthcare

Cited by 21